disitamab
seagen,rongchang pharma,RemeGen
['urothelial', 'rc48-c005']
rc48-adc for metastatic #urothelialcarcinoma with her2-positive: combined analysis of rc48-c005 and rc48-c009 trials. presentation by xinan sheng, md. #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology